Warning: JavaScript is disabled in your browser. Some features of this site may not work properly.
Skip to main content
Main Menu
Careers
Make an Appointment
COVID-19
Patient Information
For Clinicians
×
What type of appointment are you looking for?
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Clinical Trial
Pediatric Leukemia, Pediatric Hodgkin Lymphoma
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Clinical Trial
Pediatric Germ Cell Tumors
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Clinical Trial
Pediatric Cancer
The Project Every Child Protocol: A Registry, Eligibility, Screening, Biology and Outcome Study
Clinical Trial
Pediatric Cancer
